650 related articles for article (PubMed ID: 11223354)
1. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
2. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
Shaarawy M; Zaki S; Ramzi AM; Salem ME; El-Minawi AM
J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
Ayatollahi M; Geramizadeh B; Samsami A
Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
[TBL] [Abstract][Full Text] [Related]
4. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine in late pregnancies complicated with preeclampsia and in newborns.
Baksu A; Taskin M; Goker N; Baksu B; Uluocak A
Am J Perinatol; 2006 Jan; 23(1):31-5. PubMed ID: 16450270
[TBL] [Abstract][Full Text] [Related]
6. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
[TBL] [Abstract][Full Text] [Related]
7. Maternal plasma transforming growth factor-beta1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Enquobahrie DA; Williams MA; Qiu C; Woelk GB; Mahomed K
J Matern Fetal Neonatal Med; 2005 May; 17(5):343-8. PubMed ID: 16147848
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
9. Preeclampsia and fetal growth.
Odegård RA; Vatten LJ; Nilsen ST; Salvesen KA; Austgulen R
Obstet Gynecol; 2000 Dec; 96(6):950-5. PubMed ID: 11084184
[TBL] [Abstract][Full Text] [Related]
10. Plasma uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study.
Hawkins TL; Roberts JM; Mangos GJ; Davis GK; Roberts LM; Brown MA
BJOG; 2012 Mar; 119(4):484-92. PubMed ID: 22251368
[TBL] [Abstract][Full Text] [Related]
11. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia.
Naicker T; Khedun SM; Moodley J
J Obstet Gynaecol; 2002 May; 22(3):279-82. PubMed ID: 12521499
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance.
Weisz B; Cohen O; Homko CJ; Schiff E; Sivan E
Am J Perinatol; 2005 Apr; 22(3):139-44. PubMed ID: 15838747
[TBL] [Abstract][Full Text] [Related]
14. Role of serum leptin level as a marker of severity of pre eclampsia.
Mumtaz F; Memon AR; Yousfani S; Tahir SM; Khushk I; Memon M; Memon A
J Ayub Med Coll Abbottabad; 2008; 20(1):13-5. PubMed ID: 19024177
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth.
Ostlund E; Tally M; Fried G
Obstet Gynecol; 2002 Sep; 100(3):567-73. PubMed ID: 12220780
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia.
Fasshauer M; Seeger J; Waldeyer T; Schrey S; Ebert T; Kratzsch J; Lössner U; Blüher M; Stumvoll M; Faber R; Stepan H
Am J Hypertens; 2008 May; 21(5):582-6. PubMed ID: 18437151
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
[TBL] [Abstract][Full Text] [Related]
20. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
Ebrashy A; Azmy O; Ibrahim M; Waly M; Edris A
Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
